← Browse by Condition
Medical Condition

relapsed refractory lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05189093 Phase 1, Phase 2
Recruiting

Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma

Enrollment
99 pts
Location
China
Sponsor
Hangzhou Hanx Biopharmaceutica...
View Trial →